Description
Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting edge field of nanotherapeutics. This book reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the blood–brain barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches, helping to reshape the landscape of neurological healthcare. This book provides a comprehensive resource for clinicians, researchers, and students in the fields of neurology and nanotherapeutics.• Reviews the complexities of treatment strategies and the transformative role of nanotechnology in reshap ing therapeutic interventions• Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nano therapeutic approaches• Provides current updates on advanced target-based nanotherapeutics
Table of Contents
1. Concepts, types, and treatment strategies for neurodegenerative disorders2. Mechanisms of transport across the Blood: Brain Barrier3. Need for nanotherapeutics to combat neurodegenerative disorders4. Nanotechnology mediated drug delivery for addressing protein aggregation5. Nanocarriers focusing on synuclein misfolding as a therapeutic target6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders8. Nanocarrier-assisted delivery of drug(s)/genetic material for the targeted treatment of neurodegenerative disease9. Nanotherapeutics targeting neuroinflammation10. Nanocarriers mediated DNA repair mechanism against neurological disorders11. Nanotherapy for targeted inhibition of protein kinase R-like endoplasmic reticulum kinase: Unraveling stress-induced endoplasmic reticulum kinase12. Nanotechnological and molecular strategies for targeted modulation of microgliain neurodegenerativ ediseases13. Nanocarriers unveiling ferroptosis as a potential therapeutic target14. Proteostasis maintenance through nanotechnology: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders17. Targeting glial cells through nanotherapeutic strategies in neurological disorders18. Oligodendrocytes as an emerging therapeutic targets in neurological disorders
